Our next-generation LIVING-ORGAN systems support researchers in developing tangible healthcare products and innovations. Line-of-sight to patients is important to us and sits closely with our strong moral objective to improve patients lives.
We progress an asset from a pipeline hypothesis through to clinical trial via three packages:
Package 1 - FAST-TO-POC: Quick to fail/proceed analysis of a pre-pipeline asset with a focus on safety. De-risking investments and increasing confidence that an asset will proceed to an MHRA/EMA/FDA submission
Package 2 - INTERNAL R&D in Stealth: Rapid generation of non reportable data of an asset - Detailed safety, immune profiling, organ-specific toxicities, evaluation of efficacy, on/off target effects. Enables commercially safe fail-iterate-repeat experiments
Package 3 - MHRA/EMA/IND READY DATA: Preclinical Pharmacology and Toxicology Studies – to confirm an asset is reasonably safe for initial testing in humans.
We are FASTER – We are a non-bureaucratic organisation. Our models do not need regulatory approval, meaning time-to-start is in days rather than months, resulting in high intensity data generation. We are responsive to data, allowing study designs to pivot and enabling highly iterative R&D.
We are BETTER – We are a team of world leading experts with a collective experience in decades. Our technology is the most advanced in the world, only using state-of-the-art critical care equipment and MHRA/EMA/FDA approved tech.
We are CHEAPER – On average we result in a 90% cost-saving compared to NHP in-vivo experiments. We act as your external ‘white-label’ R&D partner, significantly reducing your infrastructure costs and enabling a fee-per-project service.
We are SECURE – We do not claim any IP related to your innovations. We serve a global market, with partners in the UK, Europe and America. Our team of data analysts and senior scientists provide a complete data package for 'stealth' R&D or clinical trial submission
Company Details
- Employees
- 19
- Founded
- 2021
- Address
- The Pebble Farm, Styal,cheshire Sk9 4ld,united Kingdom
- Industry
- Biotechnology
- Website
- https://pebble.bio/
- HQ
- Styal, Cheshire
Pebble Biotechnology Laboratories Questions
Pebble Biotechnology Laboratories's website is https://pebble.bio/
Pebble Biotechnology Laboratories's LinkedIn profile is https://uk.linkedin.com/company/pebble-biotechnology-laboratories
Pebble Biotechnology Laboratories has
19 employees.
View email and phone details for 19
employees at Pebble Biotechnology Laboratories.
Pebble Biotechnology Laboratories's industry is
Biotechnology
Pebble Biotechnology Laboratories's top competitors are
Plume Biotechnology,
Vertex Pharmaceuticals,
The Pebble Institute Cic,
Genz Biotechnology,
Cizzle Biotechnology Plc,
Arcis Biotechnology,
Ab Biotechnology Limited,
Environmental Biotechnology Innovation Centre,
King’s Biotechnology And Synthetic Biology Society,
Enbiosis Biotechnology.
Pebble Biotechnology Laboratories's categories are Biotechnology
Pebble Biotechnology Laboratories's founding year is 2021
